Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > RDW on youtube posted today

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Dec 02, 2023 10:57am

228 Views

Post# 35765072

RE:RE:RE:RE:RE:RE:RDW on youtube posted today

tdon1229 wrote: I don't see an error.
Treat the rest by the end of 2024 (hopefully).
Add 450 days to the end of treatment to get to mid 2026 for data collection.
Add six months to cycle through the FDA and receive approval (hopefully).

Now reread the Forward Looking Statements disclaimer.

Correct me if wrong, I was under the belief when a company was awarded BTD & AA for a segment of the patient population that was unresponsive then that company (Theralase) could immediately sell that treatment to that patient population which is 30 to 40 percent of NMIBC in a given year.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages